Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma

NCT04280848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: UCPVax
DRUG: Temozolomide

Sponsor

Centre Hospitalier Universitaire de Besancon